CJEU (Synthetic marijuana not a "medicinal product")

Authors
Publication date 2014
Journal European Journal of Risk Regulation
Volume | Issue number 2014 | 4
Pages (from-to) 548-552
Organisations
  • Faculty of Law (FdR) - Centre for the Study of European Contract Law (CSECL)
Abstract
Joined Cases C-358/13 and C-181/14, Markus D. and G. Substances which produce effects that merely modify physiological functions but which are not such as to have any beneficial effects, either immediately or in the long term, on human health, are consumed solely to induce a state of intoxication and are, as such, harmful to human health do not fall within the scope of the definition of a "medicinal product" in the Directive 2001/83 (official headnote). Consumer safety and medicines control legislation is not suitable to penalise the introduction of new psychoactive substances on European markets (author’s headnote). Art 1(2)(b) Directive 2001/83.
Document type Case note
Language English
Published at http://www.lexxion.de/en/verlagsprogramm-shop/details/5231/455/ejrr/ejrr-4/2014/synthetic-marijuana-not-a-%E2%80%9Cmedicinal-product%E2%80%9D.html
Permalink to this page
Back